Structural basis for the constitutive activity and immunomodulatory properties of the Epstein-Barr virus-encoded G protein-coupled receptor BILF1

Adams, 2010, PHENIX: a comprehensive Python-based system for macromolecular structure solution, Acta Crystallogr. D Biol. Crystallogr., 66, 213, 10.1107/S0907444909052925 Audet, 2019, Crystal structure of misoprostol bound to the labor inducer prostaglandin E2 receptor, Nat. Chem. Biol., 15, 11, 10.1038/s41589-018-0160-y Beisser, 2005, The Epstein-Barr virus BILF1 gene encodes a G protein-coupled receptor that inhibits phosphorylation of RNA-dependent protein kinase, J. Virol., 79, 441, 10.1128/JVI.79.1.441-449.2005 Burg, 2015, Structural basis for chemokine recognition and activation of a viral G protein-coupled receptor, Science, 347, 1113, 10.1126/science.aaa5026 Burger, 1999, Point mutation causing constitutive signaling of CXCR2 leads to transforming activity similar to Kaposi’s sarcoma herpesvirus-G protein-coupled receptor, J. Immunol., 163, 2017, 10.4049/jimmunol.163.4.2017 Canals, 2008, Constitutive activity of the cannabinoid CB1 receptor regulates the function of co-expressed Mu opioid receptors, J. Biol. Chem., 283, 11424, 10.1074/jbc.M710300200 Chakravorty, 2019, Integrated pan-cancer map of EBV-associated neoplasms reveals functional host–virus interactions, Cancer Res., 79, 6010, 10.1158/0008-5472.CAN-19-0615 Chen, 2002, Mutation of a single TMVI residue, Phe(282), in the β(2)-adrenergic receptor results in structurally distinct activated receptor conformations, Biochemistry, 41, 6045, 10.1021/bi012189c Croll, 2018, ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps, Acta Crystallogr. D Struct. Biol., 74, 519, 10.1107/S2059798318002425 Dukkipati, 2008, BacMam system for high-level expression of recombinant soluble and membrane glycoproteins for structural studies, Protein Expr. Purif., 62, 160, 10.1016/j.pep.2008.08.004 Emsley, 2004, Coot: model-building tools for molecular graphics, Acta Crystallogr. D Biol. Crystallogr., 60, 2126, 10.1107/S0907444904019158 Fan, 2019, Structural basis for ligand recognition of the human thromboxane A2 receptor, Nat. Chem. Biol., 15, 27, 10.1038/s41589-018-0170-9 Fares, 2019, Distinct Roles of Extracellular Domains in the Epstein-Barr Virus-Encoded BILF1 Receptor for Signaling and Major Histocompatibility Complex Class I Downregulation, MBio, 10, 1, 10.1128/mBio.01707-18 Farrell, 2019, Epstein-Barr Virus and Cancer, Annu. Rev. Pathol., 14, 29, 10.1146/annurev-pathmechdis-012418-013023 Flock, 2017, Selectivity determinants of GPCR-G-protein binding, Nature, 545, 317, 10.1038/nature22070 Fritze, 2003, Role of the conserved NPxxY(x)5,6F motif in the rhodopsin ground state and during activation, Proc. Natl. Acad. Sci. USA, 100, 2290, 10.1073/pnas.0435715100 Gewurz, 2001, Antigen presentation subverted: Structure of the human cytomegalovirus protein US2 bound to the class I molecule HLA-A2, Proc. Natl. Acad. Sci. USA, 98, 6794, 10.1073/pnas.121172898 Goddard, 2018, UCSF ChimeraX: Meeting modern challenges in visualization and analysis, Protein Sci., 27, 14, 10.1002/pro.3235 Gómez Tamayo, 2018, GPCR-SAS: A web application for statistical analyses on G protein-coupled receptors sequences, PLoS ONE, 13, e0199843, 10.1371/journal.pone.0199843 Griffin, 2013, EBV BILF1 evolved to downregulate cell surface display of a wide range of HLA class I molecules through their cytoplasmic tail, J. Immunol., 190, 1672, 10.4049/jimmunol.1102462 De Groof, 2021, Viral G Protein-Coupled Receptors: Attractive Targets for Herpesvirus-Associated Diseases, Pharmacol. Rev., 73, 828, 10.1124/pharmrev.120.000186 Heydorn, 2004, Identification of a novel site within G protein α subunits important for specificity of receptor-G protein interaction, Mol. Pharmacol., 66, 250, 10.1124/mol.66.2.250 Heymann, 2018, Guidelines for using Bsoft for high resolution reconstruction and validation of biomolecular structures from electron micrographs, Protein Sci., 27, 159, 10.1002/pro.3293 Isberg, 2015, Generic GPCR residue numbers - aligning topology maps while minding the gaps, Trends Pharmacol. Sci., 36, 22, 10.1016/j.tips.2014.11.001 Ishido, 2000, Downregulation of major histocompatibility complex class I molecules by Kaposi’s sarcoma-associated herpesvirus K3 and K5 proteins, J. Virol., 74, 5300, 10.1128/JVI.74.11.5300-5309.2000 Jaeger, 2019, Structural Basis for Allosteric Ligand Recognition in the Human CC Chemokine Receptor 7, Cell, 178, 1222, 10.1016/j.cell.2019.07.028 Joosten, 2011, A series of PDB related databases for everyday needs, Nucleic Acids Res., 39, D411, 10.1093/nar/gkq1105 Kang, 2018, Cryo-EM structure of human rhodopsin bound to an inhibitory G protein, Nature, 558, 553, 10.1038/s41586-018-0215-y Kato, 2019, Conformational transitions of a neurotensin receptor 1-Gi1 complex, Nature, 572, 80, 10.1038/s41586-019-1337-6 Koehl, 2018, Structure of the μ-opioid receptor-Gi protein complex, Nature, 558, 547, 10.1038/s41586-018-0219-7 Kostenis, 2005, A highly conserved glycine within linker I and the extreme C terminus of G protein alpha subunits interact cooperatively in switching G protein-coupled receptor-to-effector specificity, J. Pharmacol. Exp. Ther., 313, 78, 10.1124/jpet.104.080424 Krishna Kumar, 2019, Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex, Cell, 176, 448, 10.1016/j.cell.2018.11.040 Liebschner, 2019, Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix, Acta Crystallogr. D Struct. Biol., 75, 861, 10.1107/S2059798319011471 Lin, 2020, Structural basis of ligand recognition and self-activation of orphan GPR52, Nature, 579, 152, 10.1038/s41586-020-2019-0 Liu, 2020, Structural basis of CXC chemokine receptor 2 activation and signalling, Nature, 585, 135, 10.1038/s41586-020-2492-5 Lyngaa, 2010, Cell transformation mediated by the Epstein-Barr virus G protein-coupled receptor BILF1 is dependent on constitutive signaling, Oncogene, 29, 4388, 10.1038/onc.2010.173 Maeda, 2018, Development of an antibody fragment that stabilizes GPCR/G-protein complexes, Nat. Commun., 9, 3712, 10.1038/s41467-018-06002-w Maeda, 2019, Structures of the M1 and M2 muscarinic acetylcholine receptor/G-protein complexes, Science, 364, 552, 10.1126/science.aaw5188 Mastronarde, 2005, Automated electron microscope tomography using robust prediction of specimen movements, J. Struct. Biol., 152, 36, 10.1016/j.jsb.2005.07.007 Meyrath, 2020, The atypical chemokine receptor ACKR3/CXCR7 is a broad-spectrum scavenger for opioid peptides, Nat. Commun., 11, 3033, 10.1038/s41467-020-16664-0 Miles, 2018, Viral GPCR US28 can signal in response to chemokine agonists of nearly unlimited structural degeneracy, eLife, 7, e35850, 10.7554/eLife.35850 Montaner, 2013, Molecular mechanisms deployed by virally encoded G protein-coupled receptors in human diseases, Annu. Rev. Pharmacol. Toxicol., 53, 331, 10.1146/annurev-pharmtox-010510-100608 Morimoto, 2019, Crystal structure of the endogenous agonist-bound prostanoid receptor EP3, Nat. Chem. Biol., 15, 8, 10.1038/s41589-018-0171-8 Mundo, 2020, Frequent traces of EBV infection in Hodgkin and non-Hodgkin lymphomas classified as EBV-negative by routine methods: expanding the landscape of EBV-related lymphomas, Mod. Pathol., 33, 2407, 10.1038/s41379-020-0575-3 de Munnik, 2015, Modulation of cellular signaling by herpesvirus-encoded G protein-coupled receptors, Front. Pharmacol., 6, 40, 10.3389/fphar.2015.00040 Murphy, 1994, The molecular biology of leukocyte chemoattractant receptors, Annu. Rev. Immunol., 12, 593, 10.1146/annurev.iy.12.040194.003113 Nicholls, 2008, Identification of a putative intracellular allosteric antagonist binding-site in the CXC chemokine receptors 1 and 2, Mol. Pharmacol., 74, 1193, 10.1124/mol.107.044610 Nijmeijer, 2010, The Epstein-Barr virus-encoded G protein-coupled receptor BILF1 hetero-oligomerizes with human CXCR4, scavenges Gαi proteins, and constitutively impairs CXCR4 functioning, J. Biol. Chem., 285, 29632, 10.1074/jbc.M110.115618 Olivella, 2013, The role of Cysteine 6.47 in class A GPCRs, BMC Struct. Biol., 13, 3, 10.1186/1472-6807-13-3 Oswald, 2016, Intracellular allosteric antagonism of the CCR9 receptor, Nature, 540, 462, 10.1038/nature20606 Paulsen, 2005, Epstein-Barr virus-encoded BILF1 is a constitutively active G protein-coupled receptor, J. Virol., 79, 536, 10.1128/JVI.79.1.536-546.2005 Pettersen, 2004, UCSF Chimera--a visualization system for exploratory research and analysis, J. Comput. Chem., 25, 1605, 10.1002/jcc.20084 Pettersen, 2021, UCSF ChimeraX: Structure visualization for researchers, educators, and developers, Protein Sci., 30, 70, 10.1002/pro.3943 Qin, 2015, Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine, Science, 347, 1117, 10.1126/science.1261064 Quinn, 2014, Cooperation between Epstein-Barr virus immune evasion proteins spreads protection from CD8+ T cell recognition across all three phases of the lytic cycle, PLoS Pathog., 10, e1004322, 10.1371/journal.ppat.1004322 Reeves, 2002, Structure and function in rhodopsin: A tetracycline-inducible system in stable mammalian cell lines for high-level expression of opsin mutants, Proc. Natl. Acad. Sci. USA, 99, 13419, 10.1073/pnas.212519299 Salchow, 2010, A common intracellular allosteric binding site for antagonists of the CXCR2 receptor, Br. J. Pharmacol., 159, 1429, 10.1111/j.1476-5381.2009.00623.x Schuren, 2016, Recent advances in viral evasion of the MHC Class I processing pathway, Curr. Opin. Immunol., 40, 43, 10.1016/j.coi.2016.02.007 Schwartz, 1996, Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein, Nat. Med., 2, 338, 10.1038/nm0396-338 Spiess, 2015, Identification and functional comparison of seven-transmembrane G-protein-coupled BILF1 receptors in recently discovered nonhuman primate lymphocryptoviruses, J. Virol., 89, 2253, 10.1128/JVI.02716-14 Tierney, 2015, Unexpected patterns of Epstein-Barr virus transcription revealed by a high throughput PCR array for absolute quantification of viral mRNA, Virology, 474, 117, 10.1016/j.virol.2014.10.030 Toyoda, 2019, Ligand binding to human prostaglandin E receptor EP4 at the lipid-bilayer interface, Nat. Chem. Biol., 15, 18, 10.1038/s41589-018-0131-3 Wang, 2020, Structural features of activated GPCR signaling complexes, Curr. Opin. Struct. Biol., 63, 82, 10.1016/j.sbi.2020.04.008 Waterhouse, 2018, SWISS-MODEL: homology modelling of protein structures and complexes, Nucleic Acids Res., 46, W296, 10.1093/nar/gky427 Wiertz, 1996, The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol, Cell, 84, 769, 10.1016/S0092-8674(00)81054-5 Yang, 2018, Structural basis of ligand binding modes at the neuropeptide Y Y1 receptor, Nature, 556, 520, 10.1038/s41586-018-0046-x Young, 2016, Epstein-Barr virus: more than 50 years old and still providing surprises, Nat. Rev. Cancer, 16, 789, 10.1038/nrc.2016.92 Zhang, 2016, Gctf: Real-time CTF determination and correction, J. Struct. Biol., 193, 1, 10.1016/j.jsb.2015.11.003 Zhang, 2020, The ORF8 Protein of SARS-CoV-2 Mediates Immune Evasion through Potently Downregulating MHC-I, bioRxiv Zheng, 2017, MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy, Nat. Methods, 14, 331, 10.1038/nmeth.4193 Zheng, 2016, Structure of CC chemokine receptor 2 with orthosteric and allosteric antagonists, Nature, 540, 458, 10.1038/nature20605 Zhou, 2019, Common activation mechanism of class A GPCRs, eLife, 8, e50279, 10.7554/eLife.50279 Ziffert, 2020, Unusually persistent Gαi-signaling of the neuropeptide Y2 receptor depletes cellular Gi/o pools and leads to a Gi-refractory state, Cell Commun. Signal., 18, 49, 10.1186/s12964-020-00537-6 Zivanov, 2018, New tools for automated high-resolution cryo-EM structure determination in RELION-3, eLife, 7, e42166, 10.7554/eLife.42166 Zuo, 2009, The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradation, PLoS Pathog., 5, e1000255, 10.1371/journal.ppat.1000255 Zuo, 2011, The Epstein-Barr virus-encoded BILF1 protein modulates immune recognition of endogenously processed antigen by targeting major histocompatibility complex class I molecules trafficking on both the exocytic and endocytic pathways, J. Virol., 85, 1604, 10.1128/JVI.01608-10